HYDROFARM HOLDINGS GROUP, INC. quarterly report, Q2 FY2022

Hydrofarm Holdings Group, Inc. — Q2 2022 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2022. Hydrofarm manufactures and distributes controlled-environment agriculture equipment and supplies, primarily in the U.S. and Canada, and reports as one segment. Unless otherwise stated, amounts below are in U.S. dollars.

Financial performance

MetricQ2 2022Q2 2021Six months 2022Six months 2021
Net sales$97.5 million$133.8 million$208.9 million$245.2 million
Gross profit / margin$7.3 million / 7.5%$29.6 million / 22.1%$23.9 million / 11.5%$52.8 million / 21.5%
Operating income (loss)$(208.2) million$2.3 million$(234.6) million$8.7 million
Net income (loss)$(203.3) million$2.3 million$(226.6) million$7.2 million
Adjusted EBITDA (non-GAAP)$(6.8) million$16.2 million$(3.8) million$26.1 million
  • Q2 sales fell 27.1%; first-half sales fell 14.8%. Management attributed the declines primarily to lower product volumes amid agricultural oversupply and reduced cannabis growing activity. Acquired brands partly offset organic sales declines; pricing and mix also improved.
  • Gross margin contracted sharply, reflecting higher inventory-obsolescence reserves—$10.2 million in Q2 and $13.4 million in the first half, primarily for lighting products—as well as freight and labor costs that were higher relative to sales.
  • Q2 included a $189.6 million noncash goodwill impairment, reducing goodwill to zero. The first-half impairment total was $192.3 million, including a $2.6 million impairment of a note receivable in Q1. No intangible-asset impairment was recorded in Q2.
  • First-half SG&A was $66.2 million, up $22.1 million year over year, including higher amortization, compensation, stock-based compensation, facility and relocation costs. Q2 SG&A declined 4.7% to $26.0 million, partly because acquisition and integration costs were lower.

Cash flow, balance sheet and liquidity

  • First-half operating cash flow was $7.3 million, versus cash used of $0.5 million a year earlier, supported by working-capital reductions, including lower inventory and receivables. Investing cash outflow was $4.7 million, mainly capital spending; financing cash outflow was $3.3 million. Cash, cash equivalents and restricted cash totaled $27.4 million at June 30.
  • At June 30, cash and cash equivalents were $26.4 million and restricted cash was $1.0 million. Current assets were $227.1 million and current liabilities $71.4 million. Inventory was $157.3 million, down from $189.1 million at year-end 2021.
  • Debt totaled $121.1 million carrying value, including a $124.4 million term-loan principal balance. The loan matures in October 2028; its interest rate was locked at 8.38% through December 30, 2022. The $100 million asset-based revolver had no borrowings and approximately $70 million of borrowing availability. The company reported compliance with debt covenants.
  • Management said cash, operating cash flow and borrowing availability should fund operations, debt service and other needs for the next 12 months. It was also evaluating sales/leasebacks, asset sales and equity financing as possible contingency measures if needed. Aurora contingent consideration of $15.3 million was paid in July 2022.

Outlook, commentary and risks

  • The filing provides no specific revenue, earnings or margin guidance. Management said the duration and impact of current market conditions were uncertain and difficult to predict.
  • Management cited agricultural oversupply, weaker customer demand, macroeconomic and industry conditions, and lower cannabis-related growing activity. It reduced manufacturing and production and implemented temporary furloughs; these actions could continue.
  • Further inventory write-downs or impairment charges remain possible. The company identified inventory forecasting and obsolescence, long-lived asset valuations, supply-chain lead times and costs, interest-rate exposure, and customer and crop-market conditions as relevant risks.
  • At June 30, $124.4 million of debt was variable-rate exposure; management estimated a 100-basis-point rate increase would raise annual interest expense by about $1.2 million. The company reported no material legal proceedings expected to adversely affect it.

Key facts for investors to verify

  • Whether demand and sales volumes stabilize, and whether inventory levels and obsolescence reserves adequately reflect future demand.
  • Whether gross margins recover as reserve charges, freight and labor pressures change.
  • Whether cash generation and the approximately $70 million revolver availability remain sufficient, particularly after the July contingent-consideration payment.
  • Whether the company remains in compliance with loan covenants and how interest rates affect debt service.
  • Whether further impairment or inventory charges arise; goodwill was fully written off, while $313.5 million of net intangible assets remained at quarter-end.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.